Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Wenzhou Medical UniversityActive in the last 2 years

Zhe Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8528-6340; OpenAlex author ID A5052632473. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
3
Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

  1. Correction: Chloroxine inhibits pancreatic cancer progression through targeted antagonization of the PI3K/AKT/mTOR signaling pathway. Last author DOI 10.1007/s12094-025-03997-9↗
  2. Chloroxine inhibits pancreatic cancer progression through targeted antagonization of the PI3K/AKT/mTOR signaling pathway. Last author DOI 10.1007/s12094-023-03328-w↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yanyi Xiao · 2 shared papers, 2024–2025 · strength 0.52
  2. Miaomiao Lin · 2 shared papers, 2024–2025 · strength 0.52
  3. Qiyu Zhang · 2 shared papers, 2024–2025 · strength 0.52

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.